Responses to reductive stress in the cardiovascular system

Free Radical Biology and Medicine

Volumn 109, Issue , 2017, Pages 114-124

  Handy, Diane E ^a   Loscalzo, Joseph ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antioxidant; Cardiovascular; Hypoxia; Nox4; Nrf2; Oxidative stress; Redox; Reductive stress; crystallin

Indexed keywords

ALPHA CRYSTALLIN; BETA CRYSTALLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE 1; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSCRIPTION FACTOR NRF2; NFE2L2 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; ATHEROGENESIS; BLOOD VESSEL TONE; CARDIOMYOPATHY; CARDIOVASCULAR SYSTEM; CELL STRESS; HEART FAILURE; HOMEOSTASIS; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; REDUCTIVE STRESS; REPERFUSION INJURY; REVIEW; VASCULAR REMODELING; ANIMAL; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; OXIDATION REDUCTION REACTION; PATHOLOGY; SIGNAL TRANSDUCTION;

ALPHA-CRYSTALLIN B CHAIN; ANIMALS; CARDIOMYOPATHIES; CARDIOVASCULAR SYSTEM; CELL SURVIVAL; GENE EXPRESSION REGULATION; HEART FAILURE; HOMEOSTASIS; HUMANS; MYOCARDIAL REPERFUSION INJURY; NF-E2-RELATED FACTOR 2; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 85008186429     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.12.006     Document Type: Review

References (117)

1. Ago, T., Kuroda, J., Pain, J., Fu, C., Li, H., Sadoshima, J., Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ. Res. 106:7 (2010), 1253–1264.
2. Lassegue, B., Griendling, K.K., NADPH oxidases: functions and pathologies in the vasculature. Arterioscler. Thromb. Vasc. Biol. 30:4 (2010), 653–661.
3. Kirkman, H.N., Rolfo, M., Ferraris, A.M., Gaetani, G.F., Mechanisms of protection of catalase by NADPH. Kinetics and stoichiometry. J. Biol. Chem. 274:20 (1999), 13908–13914.
4. Flohe, L., Loschen, G., Gunzler, W.A., Eichele, E., Glutathione peroxidase, V. The kinetic mechanism. Hoppe-Seyler's Z. Physiol. Chem. 353:6 (1972), 987–999.
5. Pannala, V.R., Bazil, J.N., Camara, A.K., Dash, R.K., A biophysically based mathematical model for the catalytic mechanism of glutathione reductase. Free Radic. Biol. Med. 65 (2013), 1385–1397.
6. Rhee, S.G., Chae, H.Z., Kim, K., Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38:12 (2005), 1543–1552.
7. Kalinina, E.V., Chernov, N.N., Novichkova, M.D., Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. Biochem. Biokhimiia 79:13 (2014), 1562–1583.
8. Lee, S., Kim, S.M., Lee, R.T., Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance. Antioxid. Redox Signal. 18:10 (2013), 1165–1207.
9. Schafer, F.Q., Buettner, G.R., Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30:11 (2001), 1191–1212.
10. Oka, S., Hsu, C.P., Sadoshima, J., Regulation of cell survival and death by pyridine nucleotides. Circ. Res. 111:5 (2012), 611–627.
11. Yang, Y., Song, Y., Loscalzo, J., Regulation of the protein disulfide proteome by mitochondria in mammalian cells. Proc. Natl. Acad. Sci. USA 104:26 (2007), 10813–10817.
12. Fourquet, S., Guerois, R., Biard, D., Toledano, M.B., Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation. J. Biol. Chem. 285:11 (2010), 8463–8471.
13. McMahon, M., Itoh, K., Yamamoto, M., Hayes, J.D., Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278:24 (2003), 21592–21600.
14. Jessop, C.E., Bulleid, N.J., Glutathione directly reduces an oxidoreductase in the endoplasmic reticulum of mammalian cells. J. Biol. Chem. 279:53 (2004), 55341–55347.
15. Stein, L.R., Imai, S., The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol. Metab.: TEM 23:9 (2012), 420–428.
16. Dalakas, M.C., Park, K.Y., Semino-Mora, C., Lee, H.S., Sivakumar, K., Goldfarb, L.G., Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. New Engl. J. Med. 342:11 (2000), 770–780.
17. Vicart, P., Caron, A., Guicheney, P., Li, Z., Prevost, M.C., Faure, A., Chateau, D., Chapon, F., Tome, F., Dupret, J.M., Paulin, D., Fardeau, M., A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat. Genet. 20:1 (1998), 92–95.
18. Rajasekaran, N.S., Connell, P., Christians, E.S., Yan, L.J., Taylor, R.P., Orosz, A., Zhang, X.Q., Stevenson, T.J., Peshock, R.M., Leopold, J.A., Barry, W.H., Loscalzo, J., Odelberg, S.J., Benjamin, I.J., Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell 130:3 (2007), 427–439.
19. Wang, X., Osinska, H., Klevitsky, R., Gerdes, A.M., Nieman, M., Lorenz, J., Hewett, T., Robbins, J., Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. Circ. Res. 89:1 (2001), 84–91.
20. Wei, H., Campbell, W., Vander Heide, R.S., Heat shock-induced cardioprotection activates cytoskeletal-based cell survival pathways. Am. J. Physiol. Heart Circ. Physiol. 291:2 (2006), H638–H647.
21. Baek, S.H., Min, J.N., Park, E.M., Han, M.Y., Lee, Y.S., Lee, Y.J., Park, Y.M., Role of small heat shock protein HSP25 in radioresistance and glutathione-redox cycle. J. Cell. Physiol. 183:1 (2000), 100–107.
22. Arrigo, A.P., Virot, S., Chaufour, S., Firdaus, W., Kretz-Remy, C., Diaz-Latoud, C., Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced form and by decreasing iron intracellular levels. Antioxid. Redox Signal. 7:3–4 (2005), 414–422.
23. Zhang, X., Min, X., Li, C., Benjamin, I.J., Qian, B., Zhang, X., Ding, Z., Gao, X., Yao, Y., Ma, Y., Cheng, Y., Liu, L., Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27. Hypertension 55:6 (2010), 1412–1417.
24. Shi, R., Huang, C.C., Aronstam, R.S., Ercal, N., Martin, A., Huang, Y.W., N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes. BMC Pharmacol., 9, 2009, 7.
25. Xiong, Y., Liu, X., Lee, C.P., Chua, B.H., Ho, Y.S., Attenuation of doxorubicin-induced contractile and mitochondrial dysfunction in mouse heart by cellular glutathione peroxidase. Free Radic. Biol. Med. 41:1 (2006), 46–55.
26. Zhang, H., Limphong, P., Pieper, J., Liu, Q., Rodesch, C.K., Christians, E., Benjamin, I.J., Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 26:4 (2012), 1442–1451.
27. Singh, F., Charles, A.L., Schlagowski, A.I., Bouitbir, J., Bonifacio, A., Piquard, F., Krahenbuhl, S., Geny, B., Zoll, J., Reductive stress impairs myoblasts mitochondrial function and triggers mitochondrial hormesis. Biochim. Biophys. Acta 1853:7 (2015), 1574–1585.
28. Kannan, S., Muthusamy, V.R., Whitehead, K.J., Wang, L., Gomes, A.V., Litwin, S.E., Kensler, T.W., Abel, E.D., Hoidal, J.R., Rajasekaran, N.S., Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy. Cardiovasc. Res. 100:1 (2013), 63–73.
29. Rajasekaran, N.S., Varadharaj, S., Khanderao, G.D., Davidson, C.J., Kannan, S., Firpo, M.A., Zweier, J.L., Benjamin, I.J., Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice. Antioxid. Redox Signal. 14:6 (2011), 957–971.
30. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., Yamamoto, M., Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24:16 (2004), 7130–7139.
31. Dialynas, G., Shrestha, O.K., Ponce, J.M., Zwerger, M., Thiemann, D.A., Young, G.H., Moore, S.A., Yu, L., Lammerding, J., Wallrath, L.L., Myopathic lamin mutations cause reductive stress and activate the nrf2/keap-1 pathway. PLoS Genet., 11(5), 2015, e1005231.
32. Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.S., Ueno, I., Sakamoto, A., Tong, K.I., Kim, M., Nishito, Y., Iemura, S., Natsume, T., Ueno, T., Kominami, E., Motohashi, H., Tanaka, K., Yamamoto, M., The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12:3 (2010), 213–223.
33. Wang, W., Li, S., Wang, H., Li, B., Shao, L., Lai, Y., Horvath, G., Wang, Q., Yamamoto, M., Janicki, J.S., Wang, X.L., Tang, D., Cui, T., Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins. J. Mol. Cell. Cardiol. 72 (2014), 305–315.
34. Wang, S., Kaufman, R.J., The impact of the unfolded protein response on human disease. J. Cell Biol. 197:7 (2012), 857–867.
35. Eletto, D., Chevet, E., Argon, Y., Appenzeller-Herzog, C., Redox controls UPR to control redox. J. Cell Sci. 127:Pt 17 (2014), 3649–3658.
36. Cullinan, S.B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R.J., Diehl, J.A., Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 23:20 (2003), 7198–7209.
37. Jiao, Q., Sanbe, A., Zhang, X., Liu, J.P., Minamisawa, S., alphaB-Crystallin R120G variant causes cardiac arrhythmias and alterations in the expression of Ca(2+) -handling proteins and endoplasmic reticulum stress in mice. Clin. Exp. Pharmacol. Physiol. 41:8 (2014), 589–599.
38. Matsushima, S., Kuroda, J., Zhai, P., Liu, T., Ikeda, S., Nagarajan, N., Oka, S., Yokota, T., Kinugawa, S., Hsu, C.P., Li, H., Tsutsui, H., Sadoshima, J., Tyrosine kinase FYN negatively regulates NOX4 in cardiac remodeling. J. Clin. Investig. 126:9 (2016), 3403–3416.
39. Zhang, M., Brewer, A.C., Schroder, K., Santos, C.X., Grieve, D.J., Wang, M., Anilkumar, N., Yu, B., Dong, X., Walker, S.J., Brandes, R.P., Shah, A.M., NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc. Natl. Acad. Sci. USA 107:42 (2010), 18121–18126.
40. Byrne, J.A., Grieve, D.J., Bendall, J.K., Li, J.M., Gove, C., Lambeth, J.D., Cave, A.C., Shah, A.M., Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 93:9 (2003), 802–805.
41. Looi, Y.H., Grieve, D.J., Siva, A., Walker, S.J., Anilkumar, N., Cave, A.C., Marber, M., Monaghan, M.J., Shah, A.M., Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 51:2 (2008), 319–325.
42. Doerries, C., Grote, K., Hilfiker-Kleiner, D., Luchtefeld, M., Schaefer, A., Holland, S.M., Sorrentino, S., Manes, C., Schieffer, B., Drexler, H., Landmesser, U., Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ. Res. 100:6 (2007), 894–903.
43. Brewer, A.C., Murray, T.V., Arno, M., Zhang, M., Anilkumar, N.P., Mann, G.E., Shah, A.M., Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. Free Radic. Biol. Med. 51:1 (2011), 205–215.
44. Semenza, G.L., Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE: Signal Transduct. Knowl. Environ., 2007(407), 2007 (cm8.).
45. Semenza, G.L., Hypoxia-inducible factors in physiology and medicine. Cell 148:3 (2012), 399–408.
46. Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M.D., Sadoshima, J., NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. USA 107:35 (2010), 15565–15570.
47. Matsushima, S., Kuroda, J., Ago, T., Zhai, P., Ikeda, Y., Oka, S., Fong, G.H., Tian, R., Sadoshima, J., Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1alpha and upregulation of peroxisome proliferator-activated receptor-alpha. Circ. Res. 112:8 (2013), 1135–1149.
48. He, Q., Wang, M., Petucci, C., Gardell, S.J., Han, X., Rotenone induces reductive stress and triacylglycerol deposition in C2C12 cells. Int. J. Biochem. Cell Biol. 45:12 (2013), 2749–2755.
49. Duncan, J.G., Bharadwaj, K.G., Fong, J.L., Mitra, R., Sambandam, N., Courtois, M.R., Lavine, K.J., Goldberg, I.J., Kelly, D.P., Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Circulation 121:3 (2010), 426–435.
50. Yu, Q., Lee, C.F., Wang, W., Karamanlidis, G., Kuroda, J., Matsushima, S., Sadoshima, J., Tian, R., Elimination of NADPH oxidase activity promotes reductive stress and sensitizes the heart to ischemic injury. J. Am. Heart Assoc., 3(1), 2014, e000555.
51. Touyz, R.M., Montezano, A.C., Vascular Nox4: a multifarious NADPH oxidase. Circ. Res. 110:9 (2012), 1159–1161.
52. Ray, R., Murdoch, C.E., Wang, M., Santos, C.X., Zhang, M., Alom-Ruiz, S., Anilkumar, N., Ouattara, A., Cave, A.C., Walker, S.J., Grieve, D.J., Charles, R.L., Eaton, P., Brewer, A.C., Shah, A.M., Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler. Thromb. Vasc. Biol. 31:6 (2011), 1368–1376.
53. Ali, Z.A., de Jesus Perez, V., Yuan, K., Orcholski, M., Pan, S., Qi, W., Chopra, G., Adams, C., Kojima, Y., Leeper, N.J., Qu, X., Zaleta-Rivera, K., Kato, K., Yamada, Y., Oguri, M., Kuchinsky, A., Hazen, S.L., Jukema, J.W., Ganesh, S.K., Nabel, E.G., Channon, K., Leon, M.B., Charest, A., Quertermous, T., Ashley, E.A., Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1. J. Clin. Investig. 124:12 (2014), 5159–5174.
54. Drouin, A., Thorin-Trescases, N., Hamel, E., Falck, J.R., Thorin, E., Endothelial nitric oxide synthase activation leads to dilatory H2O2 production in mouse cerebral arteries. Cardiovasc. Res. 73:1 (2007), 73–81.
55. Oltman, C.L., Kane, N.L., Miller, F.J. Jr., Spector, A.A., Weintraub, N.L., Dellsperger, K.C., Reactive oxygen species mediate arachidonic acid-induced dilation in porcine coronary microvessels. Am. J. Physiol. Heart Circ. Physiol. 285:6 (2003), H2309–H2315.
56. Modrick, M.L., Didion, S.P., Lynch, C.M., Dayal, S., Lentz, S.R., Faraci, F.M., Role of hydrogen peroxide and the impact of glutathione peroxidase-1 in regulation of cerebral vascular tone. J. Cereb. Blood Flow. Metab.: Off. J. Int. Soc. Cereb. Blood Flow. Metab. 29:6 (2009), 1130–1137.
57. Langbein, H., Brunssen, C., Hofmann, A., Cimalla, P., Brux, M., Bornstein, S.R., Deussen, A., Koch, E., Morawietz, H., NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice. Eur. Heart J. 37:22 (2016), 1753–1761.
58. Schroder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., Kruse, C., Luedike, P., Michaelis, U.R., Weissmann, N., Dimmeler, S., Shah, A.M., Brandes, R.P., Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ. Res. 110:9 (2012), 1217–1225.
59. Craige, S.M., Chen, K., Pei, Y., Li, C., Huang, X., Chen, C., Shibata, R., Sato, K., Walsh, K., Keaney, J.F. Jr., NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 124:6 (2011), 731–740.
60. Chen, L., Xiao, J., Kuroda, J., Ago, T., Sadoshima, J., Cohen, R.A., Tong, X., Both hydrogen peroxide and transforming growth factor beta 1 contribute to endothelial Nox4 mediated angiogenesis in endothelial Nox4 transgenic mouse lines. Biochim. Biophys. Acta 1842:12 Pt A (2014), 2489–2499.
61. Ichihara, S., Yamada, Y., Liu, F., Murohara, T., Itoh, K., Yamamoto, M., Ichihara, G., Ablation of the transcription factor Nrf2 promotes ischemia-induced neovascularization by enhancing the inflammatory response. Arterioscler. Thromb. Vasc. Biol. 30:8 (2010), 1553–1561.
62. Basuroy, S., Bhattacharya, S., Leffler, C.W., Parfenova, H., Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am. J. Physiol. Cell Physiol. 296:3 (2009), C422–C432.
63. Lee, D.Y., Wauquier, F., Eid, A.A., Roman, L.J., Ghosh-Choudhury, G., Khazim, K., Block, K., Gorin, Y., Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: role of mitochondrial reactive oxygen species. J. Biol. Chem. 288:40 (2013), 28668–28686.
64. Di Bartolo, B.A., Cartland, S.P., Prado-Lourenco, L., Griffith, T.S., Gentile, C., Ravindran, J., Azahri, N.S., Thai, T., Yeung, A.W., Thomas, S.R., Kavurma, M.M., Tumor necrosis. J. Am. Heart Assoc., 4(11), 2015.
65. Wang, J., Hong, Z., Zeng, C., Yu, Q., Wang, H., NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro. Free Radic. Biol. Med. 69 (2014), 278–288.
66. Li, J., Wang, J.J., Zhang, S.X., NADPH oxidase 4-derived H2O2 promotes aberrant retinal neovascularization via activation of VEGF receptor 2 pathway in oxygen-induced retinopathy. J. Diabetes Res., 2015, 2015, 963289.
67. Green, D.E., Murphy, T.C., Kang, B.Y., Kleinhenz, J.M., Szyndralewiez, C., Page, P., Sutliff, R.L., Hart, C.M., The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am. J. Respir. Cell Mol. Biol. 47:5 (2012), 718–726.
68. Wedgwood, S., Lakshminrusimha, S., Czech, L., Schumacker, P.T., Steinhorn, R.H., Increased p22(phox)/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn. Antioxid. Redox Signal. 18:14 (2013), 1765–1776.
69. Craige, S.M., Kant, S., Reif, M., Chen, K., Pei, Y., Angoff, R., Sugamura, K., Fitzgibbons, T., Keaney, J.F. Jr., Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions. Free Radic. Biol. Med. 89 (2015), 1–7.
70. Gray, S.P., Di Marco, E., Kennedy, K., Chew, P., Okabe, J., El-Osta, A., Calkin, A.C., Biessen, E.A., Touyz, R.M., Cooper, M.E., Schmidt, H.H., Jandeleit-Dahm, K.A., Reactive oxygen species Can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 36:2 (2016), 295–307.
71. Schurmann, C., Rezende, F., Kruse, C., Yasar, Y., Lowe, O., Fork, C., van de Sluis, B., Bremer, R., Weissmann, N., Shah, A.M., Jo, H., Brandes, R.P., Schroder, K., The NADPH oxidase Nox4 has anti-atherosclerotic functions. Eur. Heart J. 36:48 (2015), 3447–3456.
72. Galasso, G., Schiekofer, S., Sato, K., Shibata, R., Handy, D.E., Ouchi, N., Leopold, J.A., Loscalzo, J., Walsh, K., Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ. Res. 98:2 (2006), 254–261.
73. Fong, G.H., Takeda, K., Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 15:4 (2008), 635–641.
74. Palazon, A., Goldrath, A.W., Nizet, V., Johnson, R.S., HIF transcription factors, inflammation, and immunity. Immunity 41:4 (2014), 518–528.
75. Jurgensen, J.S., Rosenberger, C., Wiesener, M.S., Warnecke, C., Horstrup, J.H., Grafe, M., Philipp, S., Griethe, W., Maxwell, P.H., Frei, U., Bachmann, S., Willenbrock, R., Eckardt, K.U., Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 18:12 (2004), 1415–1417.
76. Guzy, R.D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K.D., Simon, M.C., Hammerling, U., Schumacker, P.T., Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1:6 (2005), 401–408.
77. Chan, S.Y., Zhang, Y.Y., Hemann, C., Mahoney, C.E., Zweier, J.L., Loscalzo, J., MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 10:4 (2009), 273–284.
78. Intlekofer, A.M., Dematteo, R.G., Venneti, S., Finley, L.W., Lu, C., Judkins, A.R., Rustenburg, A.S., Grinaway, P.B., Chodera, J.D., Cross, J.R., Thompson, C.B., Hypoxia induces production of L-2-Hydroxyglutarate. Cell Metab. 22:2 (2015), 304–311.
79. Oldham, W.M., Clish, C.B., Yang, Y., Loscalzo, J., Hypoxia-mediated increases in L-2-hydroxyglutarate coordinate the metabolic response to reductive stress. Cell Metab. 22:2 (2015), 291–303.
80. Liu, L., Shah, S., Fan, J., Park, J.O., Wellen, K.E., Rabinowitz, J.D., Malic enzyme tracers reveal hypoxia-induced switch in adipocyte NADPH pathway usage. Nat. Chem. Biol. 12:5 (2016), 345–352.
81. Peuhkurinen, K.J., Takala, T.E., Nuutinen, E.M., Hassinen, I.E., Tricarboxylic acid cycle metabolites during ischemia in isolated perfused rat heart. Am. J. Physiol. 244:2 (1983), H281–H288.
82. Ronchi, J.A., Francisco, A., Passos, L.A., Figueira, T.R., Castilho, R.F., The contribution of nicotinamide nucleotide transhydrogenase to peroxide detoxification is dependent on the respiratory state and counterbalanced by other sources of NADPH in liver mitochondria. J. Biol. Chem. 291:38 (2016), 20173–20187.
83. Jain, M., Cui, L., Brenner, D.A., Wang, B., Handy, D.E., Leopold, J.A., Loscalzo, J., Apstein, C.S., Liao, R., Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation 109:7 (2004), 898–903.
84. Hecker, P.A., Lionetti, V., Ribeiro, R.F. Jr., Rastogi, S., Brown, B.H., O'Connell, K.A., Cox, J.W., Shekar, K.C., Gamble, D.M., Sabbah, H.N., Leopold, J.A., Gupte, S.A., Recchia, F.A., Stanley, W.C., Glucose 6-phosphate dehydrogenase deficiency increases redox stress and moderately accelerates the development of heart failure. Circ. Heart Fail. 6:1 (2013), 118–126.
85. Ido, Y., Pyridine nucleotide redox abnormalities in diabetes. Antioxid. Redox Signal. 9:7 (2007), 931–942.
86. Palmeira, C.M., Rolo, A.P., Berthiaume, J., Bjork, J.A., Wallace, K.B., Hyperglycemia decreases mitochondrial function: the regulatory role of mitochondrial biogenesis. Toxicol. Appl. Pharmacol. 225:2 (2007), 214–220.
87. Gomes, A.P., Price, N.L., Ling, A.J., Moslehi, J.J., Montgomery, M.K., Rajman, L., White, J.P., Teodoro, J.S., Wrann, C.D., Hubbard, B.P., Mercken, E.M., Palmeira, C.M., Cabo, R. de, Rolo, A.P., Turner, N., Bell, E.L., Sinclair, D.A., Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155:7 (2013), 1624–1638.
88. Jack, B.H., Pearson, R.C., Crossley, M., C-terminal binding protein: a metabolic sensor implicated in regulating adipogenesis. Int. J. Biochem. Cell Biol. 43:5 (2011), 693–696.
89. Wu, X., Chang, M.S., Mitsialis, S.A., Kourembanas, S., Hypoxia regulates bone morphogenetic protein signaling through C-terminal-binding protein 1. Circ. Res. 99:3 (2006), 240–247.
90. Torzewski, M., Ochsenhirt, V., Kleschyov, A.L., Oelze, M., Daiber, A., Li, H., Rossmann, H., Tsimikas, S., Reifenberg, K., Cheng, F., Lehr, H.A., Blankenberg, S., Forstermann, U., Munzel, T., Lackner, K.J., Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27:4 (2007), 850–857.
91. Lewis, P., Stefanovic, N., Pete, J., Calkin, A.C., Giunti, S., Thallas-Bonke, V., Jandeleit-Dahm, K.A., Allen, T.J., Kola, I., Cooper, M.E., de Haan, J.B., Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 115:16 (2007), 2178–2187.
92. Kisucka, J., Chauhan, A.K., Patten, I.S., Yesilaltay, A., Neumann, C., Van Etten, R.A., Krieger, M., Wagner, D.D., Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ. Res. 103:6 (2008), 598–605.
93. Park, J.G., Yoo, J.Y., Jeong, S.J., Choi, J.H., Lee, M.R., Lee, M.N., Hwa Lee, J., Kim, H.C., Jo, H., Yu, D.Y., Kang, S.W., Rhee, S.G., Lee, M.H., Oh, G.T., Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice. Circ. Res. 109:7 (2011), 739–749.
94. Chew, P., Yuen, D.Y., Stefanovic, N., Pete, J., Coughlan, M.T., Jandeleit-Dahm, K.A., Thomas, M.C., Rosenfeldt, F., Cooper, M.E., de Haan, J.B., Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. Diabetes 59:12 (2010), 3198–3207.
95. Guo, Z., Ran, Q., Roberts, L.J. 2nd, Zhou, L., Richardson, A., Sharan, C., Wu, D., Yang, H., Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice. Free Radic. Biol. Med. 44:3 (2008), 343–352.
96. Guo, X., Yamada, S., Tanimoto, A., Ding, Y., Wang, K.Y., Shimajiri, S., Murata, Y., Kimura, S., Tasaki, T., Nabeshima, A., Watanabe, T., Kohno, K., Sasaguri, Y., Overexpression of peroxiredoxin 4 attenuates atherosclerosis in apolipoprotein E knockout mice. Antioxid. Redox Signal. 17:10 (2012), 1362–1375.
97. Cheng, F., Torzewski, M., Degreif, A., Rossmann, H., Canisius, A., Lackner, K.J., Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis. PloS One, 8(8), 2013, e72063.
98. Lubos, E., Kelly, N.J., Oldebeken, S.R., Leopold, J.A., Zhang, Y.Y., Loscalzo, J., Handy, D.E., Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation. J. Biol. Chem. 286:41 (2011), 35407–35417.
99. Wagner, A.H., Kautz, O., Fricke, K., Zerr-Fouineau, M., Demicheva, E., Guldenzoph, B., Bermejo, J.L., Korff, T., Hecker, M., Upregulation of glutathione peroxidase offsets stretch-induced proatherogenic gene expression in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29:11 (2009), 1894–1901.
100. Sciarretta, S., Zhai, P., Shao, D., Zablocki, D., Nagarajan, N., Terada, L.S., Volpe, M., Sadoshima, J., Activation of NADPH oxidase 4 in the endoplasmic reticulum promotes cardiomyocyte autophagy and survival during energy stress through the protein kinase RNA-activated-like endoplasmic reticulum kinase/eukaryotic initiation factor 2alpha/activating transcription factor 4 pathway. Circ. Res. 113:11 (2013), 1253–1264.
101. Swain, L., Kesemeyer, A., Meyer-Roxlau, S., Vettel, C., Zieseniss, A., Guntsch, A., Jatho, A., Becker, A., Nanadikar, M.S., Morgan, B., Dennerlein, S., Shah, A.M., El-Armouche, A., Nikolaev, V.O., Katschinski, D.M., Redox Imaging Using Cardiac Myocyte-specific transgenic biosensor mice. Circ. Res. 119:9 (2016), 1004–1016.
102. Touyz, R.M., Anagnostopoulou, A., De Lucca Camargo, L., Montezano, A.C., Novel biosensors reveal a shift in the redox paradigm from oxidative to reductive stress in heart disease. Circ. Res. 119:9 (2016), 969–971.
103. Handy, D.E., Lubos, E., Yang, Y., Galbraith, J.D., Kelly, N., Zhang, Y.Y., Leopold, J.A., Loscalzo, J., Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses. J. Biol. Chem. 284:18 (2009), 11913–11921.
104. Lubos, E., Loscalzo, J., Handy, D.E., Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 15:7 (2011), 1957–1997.
105. Goldstein, B.J., Mahadev, K., Wu, X., Zhu, L., Motoshima, H., Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid. Redox Signal. 7:7–8 (2005), 1021–1031.
106. Mahadev, K., Motoshima, H., Wu, X., Ruddy, J.M., Arnold, R.S., Cheng, G., Lambeth, J.D., Goldstein, B.J., The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24:5 (2004), 1844–1854.
107. McClung, J.P., Roneker, C.A., Mu, W., Lisk, D.J., Langlais, P., Liu, F., Lei, X.G., Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. USA 101:24 (2004), 8852–8857.
108. Labunskyy, V.M., Lee, B.C., Handy, D.E., Loscalzo, J., Hatfield, D.L., Gladyshev, V.N., Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice. Antioxid. Redox Signal. 14:12 (2011), 2327–2336.
109. Burgoyne, J.R., Mongue-Din, H., Eaton, P., Shah, A.M., Redox signaling in cardiac physiology and pathology. Circ. Res. 111:8 (2012), 1091–1106.
110. Ray, P.D., Huang, B.W., Tsuji, Y., Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 24:5 (2012), 981–990.
111. Prysyazhna, O., Rudyk, O., Eaton, P., Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat. Med. 18:2 (2012), 286–290.
112. Maron, B.A., Zhang, Y.Y., Handy, D.E., Beuve, A., Tang, S.S., Loscalzo, J., Leopold, J.A., Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. J. Biol. Chem. 284:12 (2009), 7665–7672.
113. Thompson, M.D., Mei, Y., Weisbrod, R.M., Silver, M., Shukla, P.C., Bolotina, V.M., Cohen, R.A., Tong, X., Glutathione adducts on sarcoplasmic/endoplasmic reticulum Ca2+ ATPase Cys-674 regulate endothelial cell calcium stores and angiogenic function as well as promote ischemic blood flow recovery. J. Biol. Chem. 289:29 (2014), 19907–19916.
114. Loscalzo, J., Adaptions to hypoxia and redox. Circ. Res. 119:4 (2016), 511–513.
115. Shen, D., Dalton, T.P., Nebert, D.W., Shertzer, H.G., Glutathione redox state regulates mitochondrial reactive oxygen production. J. Biol. Chem. 280:27 (2005), 25305–25312.
116. Gupte, S.A., Levine, R.J., Gupte, R.S., Young, M.E., Lionetti, V., Labinskyy, V., Floyd, B.C., Ojaimi, C., Bellomo, M., Wolin, M.S., Recchia, F.A., Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. J. Mol. Cell. Cardiol. 41:2 (2006), 340–349.
117. Korge, P., Calmettes, G., Weiss, J.N., Increased reactive oxygen species production during reductive stress: the roles of mitochondrial glutathione and thioredoxin reductases. Biochim. Biophys. Acta 1847:6–7 (2015), 514–525.